Bacillus coagulans is a naturally occurring bacterium found in the human gastrointestinal tract. It is used as a probiotic supplement to maintain a healthy digestive system. Bacillus coagulans products are available in the form of capsules, tablets, powder, and liquid for oral consumption. It helps improve the symptoms of gastrointestinal problems such as diarrhea, irritable bowel syndrome, acid reflux, and constipation.

The global bacillus coagulans market is estimated to be valued at US$ 722.43 Mn in 2023 and is expected to exhibit a CAGR of 12% over the forecast period 2023 to 2030, as highlighted in a new report published by Coherent Market Insights.

Market Dynamics

Rising health consciousness among consumers is the primary driver propelling the growth of the bacillus coagulans market. According to a survey by the International Food Information Council Foundation, 73% of consumers consider probiotics as an important component of their daily diet. Moreover, the COVID-19 pandemic has made people more cognizant of their health and immunity, thereby fueling the demand for probiotic supplements in the market.

Bacillus coagulans assists immune function by stimulating the activity of natural killer cells and macrophages. Therefore, it is gaining popularity as an alternative treatment for preventing infections, autoimmune disorders, and seasonal illnesses such as common cold and flu, which is propelling market growth. However, lack of awareness about the benefits of bacillus coagulans in some developing nations may hamper the market growth during the forecast period.

SWOT Analysis
Strength: The Bacillus Coagulans Market has several advantages such as the probiotic strains of Bacillus Coagulans are generally regarded as safe and have shown positive health benefits. Bacillus Coagulans strains are natural inhabitants of the human gastrointestinal tract and readily colonize in the digestive system. They help promote healthy digestion and support immune function through the production of bacteriocins and other antimicrobial compounds.

Weakness: High prices of Bacillus Coagulans supplements compared to other probiotics may restrain the market growth to some extent. Limited clinical research studies have been conducted on the specific health benefits of Bacillus Coagulans strains, which restricts the product adoption.

Opportunity: Rising awareness about preventive healthcare and gut health management opens up opportunities for Bacillus Coagulans supplements. Growing preference for natural and herbal remedies for various ailments instead of chemical-based medicines will boost the sales. Increasing adoption of probiotic drinks and dietary supplements infused with Bacillus Coagulans strains presents lucrative prospects.

Threats: Stringent regulatory policies for new strains and products may negatively impact the Bacillus Coagulans industry. High R&D costs associated with clinical validation of health claims and bringing novel products to markets also threaten the steady growth of the market.


Key Takeaways

The global Bacillus Coagulans market is expected to witness high growth. The global bacillus coagulans market is estimated to be valued at US$ 722.43 Mn in 2023 and is expected to exhibit a CAGR of 12% over the forecast period 2023 to 2030.

North America dominates the global Bacillus Coagulans market and is expected to maintain its leading position throughout the forecast period. This is attributed to increased awareness about preventive healthcare and growing popularity of probiotic supplements among consumers in the region.

Key players related content comprises Key players operating in the Bacillus Coagulans market are BASF SE (Germany), Dow (U.S.), CLARIANT (Switzerland), Nippon Paint Holdings Co., Ltd.(Japan), PPG Industries, Inc. (U.S.), The Sherwin-Williams Company (U.S.), Huntsman International LLC. (U.S.), MarvelVinyls (India), The VersaFlex Companies (U.S.), Axalta Coating Systems, LLC (U.S.), Pidilite Industries Ltd. (India), Valspar (U.S.), Rhino Linings Corporation. (U.S.), Nukote Coating Systems, Intl. (U.S.), Jotun (Norway), RODDA PAINT, CO. (U.S.), Constro Chem India Pvt. Ltd. (India), ELMET (U.S.), Aalberts Surface Technologies GmbH.(Netherlands). These companies are focused on expanding their global footprint through mergers & acquisitions and collaborations with regional players.

Explore more trending article on this topic:https://www.trendingwebwire.com/the-global-bacillus-coagulans-market-is-estimated-to-propelled-by-increasing-demand-for-probiotics/